337 related articles for article (PubMed ID: 29654915)
1. Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled Trial.
Zhong LLD; Cheng CW; Kun W; Dai L; Hu DD; Ning ZW; Xiao HT; Lin CY; Zhao L; Huang T; Tian K; Chan KH; Lam TW; Chen XR; Wong CT; Li M; Lu AP; Wu JCY; Bian ZX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1303-1310.e18. PubMed ID: 29654915
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial.
Zhong LL; Cheng CW; Chan Y; Chan KH; Lam TW; Chen XR; Wong CT; Wu JC; Bian ZX
Trials; 2013 Nov; 14():366. PubMed ID: 24180235
[TBL] [Abstract][Full Text] [Related]
3. Whether Syndrome Differentiation Affects Treatment Result: Study Protocol of MaZiRenWan () for Functional Constipation in A Randomized Controlled Trial.
Cheng CW; Zhang L; Zhao C; Zhong LL; Shi LJ; Dai L; Zheng R; Chen J; Li G; Zhai JB; Kun W; Lu AP; Shang HC; Bian ZX
Chin J Integr Med; 2019 Mar; 25(3):175-181. PubMed ID: 30109589
[TBL] [Abstract][Full Text] [Related]
4. Chinese Herbal Medicine (MaZiRenWan) Improves Bowel Movement in Functional Constipation Through Down-Regulating Oleamide.
Huang T; Zhao L; Lin CY; Lu L; Ning ZW; Hu DD; Zhong LLD; Yang ZJ; Bian ZX
Front Pharmacol; 2019; 10():1570. PubMed ID: 32038247
[TBL] [Abstract][Full Text] [Related]
5. A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients.
Cheng CW; Mok HF; Yau CWS; Chan JTM; Kang YC; Lam PY; Zhong LLD; Zhao C; Ng BFL; Kwok AOL; Tse DMW; Bian ZX
Chin Med; 2022 Mar; 17(1):31. PubMed ID: 35236375
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal medicine for functional constipation: a randomised controlled trial.
Bian ZX; Cheng CW; Zhu LZ
Hong Kong Med J; 2013 Dec; 19 Suppl 9():44-6. PubMed ID: 24473591
[TBL] [Abstract][Full Text] [Related]
7. [Acupuncture combined with Chinese herbal medicine Plantain and Senna Granule in treatment of functional constipation: a randomized, controlled trial].
Guo LK; Zhang CX; Guo XF
Zhong Xi Yi Jie He Xue Bao; 2011 Nov; 9(11):1206-14. PubMed ID: 22088586
[TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease.
Jin Z; Liu Z; Kang L; Yang A; Zhao H; Yan X; Zhang T; Gao L; Liu A; Fang B
Medicine (Baltimore); 2020 Jul; 99(28):e21145. PubMed ID: 32664145
[TBL] [Abstract][Full Text] [Related]
9. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.
Marciniak CM; Toledo S; Lee J; Jesselson M; Bateman J; Grover B; Tierny J
World J Gastroenterol; 2014 Nov; 20(43):16323-33. PubMed ID: 25473191
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
11. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Schoenfeld P; Lacy BE; Chey WD; Lembo AJ; Kurtz CB; Reasner DS; Bochenek W; Tripp K; Currie MG; Fox SM; Blakesley RE; OʼDea CR; Omniewski ND; Hall ML
Am J Gastroenterol; 2018 Jan; 113(1):105-114. PubMed ID: 29091082
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.
Christie J; Shroff S; Shahnavaz N; Carter LA; Harrison MS; Dietz-Lindo KA; Hanfelt J; Srinivasan S
Am J Gastroenterol; 2017 Feb; 112(2):356-364. PubMed ID: 27922028
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
Mueller-Lissner S; Kamm MA; Wald A; Hinkel U; Koehler U; Richter E; Bubeck J
Am J Gastroenterol; 2010 Apr; 105(4):897-903. PubMed ID: 20179697
[TBL] [Abstract][Full Text] [Related]
16. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial.
Morishita D; Tomita T; Mori S; Kimura T; Oshima T; Fukui H; Miwa H
Am J Gastroenterol; 2021 Jan; 116(1):152-161. PubMed ID: 32969946
[TBL] [Abstract][Full Text] [Related]
17. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of linaclotide for patients with chronic constipation.
Lembo AJ; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; Jeglinski BI; Johnston JM
Gastroenterology; 2010 Mar; 138(3):886-95.e1. PubMed ID: 20045700
[TBL] [Abstract][Full Text] [Related]
19. A Randomized, Double-Blind, and Placebo-Controlled Trial of Chinese Herbal Medicine in the Treatment of Childhood Constipation.
Qiao L; Wang LJ; Wang Y; Chen Y; Zhang HL; Zhang SC
Clin Transl Gastroenterol; 2021 May; 12(5):e00345. PubMed ID: 33938874
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
